U.S. Pharmacist Weekly News Update
January 29, 2020

Modifiable Factors Most Associated With Ability to Achieve T2D Glycemic Control
For patients who struggle to lower their blood sugar, some factors are simply out of their control, such as age or comorbidities. The other modifiable factors might be more important, however. Here are the key steps that patients can take to improve glycemic control.


Do PPIs Contribute to “Cancer Fog” in Some Patients Undergoing Treatment?
Medications recommended to ease digestive issues during chemo-immunotherapy might also be having an unexpected effect: impairing memory and concentration in breast cancer patients. Find out why a new study suggests proton-pump inhibitors could be causing some cognitive problems in those users.

More Evidence for Caution
in Use of Antipsychotics for
Alzheimer’s Patients

Pharmacists might want to share the information with patients who initiate antipsychotics for Alzheimer’s disease—and especially their caregivers—that they are at elevated risks for dangerous head and brain injuries that could further complicate their situation. Here is why researchers think that is occurring and why the drugs should be prescribed much more sparingly for dementia patients.

The Impact of Generic DMTs on MS Drug Costs Is Surprising
The costs of multiple-sclerosis drugs have nearly tripled over 7 years. That is especially surprising to pharmacists and others because generic versions of popular medications were approved in that time period. Here are more details.

Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App